Спорные вопросы диабетической нефропатии (часть I)


Н.И. Волкова

Кафедра внутренних болезней № 3 ГОУ ВПО РостГМУ Минздравсоцразвития России, Ростов-на-Дону
В статье рассмотрены спорные вопросы диабетической болезни почек, в т. ч. ее диагностических критериев. Кроме того, обсуждаются возможные изменения в дефиниции и классификации диабетической болезни почек.

Литература


1. Дедов И.И., Шестакова М.В. Сахарный диабет и хроническая болезнь почек. М.: Мед. информ. агентство. 2009. 484 с.
2. National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis 2007;49 (2 Suppl 2):S12–154 [598 references].
3. Jerry Yee. Diabetic Kidney Disease: Chronic Kidney Disease and Diabetes. Diabetes Spectrum. 2008;21:8–10.
4. United States Renal Data System. USRDS 2007 Annual Data Report. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, US Department of Health
and Human Services.
5. Wong T.Y.H., Choi P.C.L., Szeto C.C. et al. Renal outcome in type 2 diabetic patients with or without coexisting nondiabetic nephropathies. Diabetes Care. 2002;25: 900–905.
6. Гордеев А.В. Поражение почек у пожилых при сахарном диабете 2 типа. Автореферат дисс. д-ра мед. наук. 2002. 44 с.
7. Agardh C.D., Agardh E., Torffvit O. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: A 5 year follow-up study of 442 adult patients in routine care. Diabetes Res Clin Pract. 1997;35:113–121.
8. Christensen P.K., Larsen S., Horn T. et al. Causes of albuminuria in patients with type 2 diabetes without diabetic retinopathy. Kidney Int. 2000; 58: 1719–1731.
9. Christensen P.K., Larsen S., Horn T., Olsen S. et al. Renal function and structure in albuminuric type 2 diabetic patients without retinopathy. Nephrol Dial Transplant. 2001;16:2337–2347.
10. Klein R., Zinman B., Gardiner R. et al. ReninAngiotensin SS: The relationship of diabetic retinopathy to preclinical diabetic glomerulopathy lesions in type 1 diabetic patients: The Renin-Angiotensin System Study. Diabetes. 2005;54:527–533.
11. Schwartz M.M., Lewis E.J., LeonardMartin T. et al. Renal pathology patterns in type II diabetes mellitus: Relationship with retinopathy. The Collaborative Study Group. Nephrol Dial Transplant. 1998;1
3:2547–2552.
12. Kanauchi M., Kawano T., Uyama H., Shiiki H. et al. Discordance between retinopathy and nephropathy in type 2 diabetes. Nephron. 1998; 80: 171–174.
13. American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care 2010;33 Suppl 1:S11–61.
14. Дедов И.И., Шестакова М.В. и др. Алгоритмы по специализированной медицинской помощи больным сахарным диабетом. Издание четвертое. Министерство здравоохранения и социального развития РФ. М.: 2009. 104 c.
15. Mathiesen E.R., Ronn B., Storm B. et al. The natural course of microalbuminuria in insulindependent diabetes: A 10-year prospective study. Diabet Med. 1995;12:482–487.
16. Krolewski M., Eggers P.W., Warram J.H. Magnitude of end-stage renal disease in IDDM: A 35 year follow-up study. Kidney Int. 1996;50:2041–2046.
17. Mathiesen E.R., Hommel E., Hansen H.P. et al. Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria. BMJ. 1999;319:24–25.
18. Araki S., Haneda M., Sugimoto T. et al. Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes. Diabetes. 2005;54:2983–2987.
19. Perkins B.A., Ficociello L.H., Silva K.H. et al. Regression of microalbuminuria in type 1 diabetes. N Engl J Med. 2003;348:2285–2293.
20. Bruno G., Biggeri A., Merletti F. et al. Lowincidence of end-stage renal disease and chronic renal failure in type 2 diabetes: A 10-year prospective study. Diabetes Care. 2003;26:2353–358.
21. Adler A.I., Stevens R.J., Manley S.E. et al. Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 2003;63:225–232.
22. Rachmani R., Levi Z., Lidar M. et al. Considerations about the threshold value of microalbuminuria in patients with diabetes mellitus: Lessons from an 8-year follow-up study of 599 patients. Diabetes Res Clin Pract. 2000;49:187–194.
23. Caramori M.L., Kim Y., Huang C. et al. Cellular basis of diabetic nephropathy: 1. Study design and renal structural- functional relationships in patients with long-standing type 1 diabetes. Diabetes. 2002;51:506–513.
24. Caramori M.L., Fioretto P., Mauer M. Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: An indicator of more advanced glomerular lesions. Diabetes. 2003;52:1036–1040.
25. Lane P.H., Steffes M.W., Mauer S.M. Glomerular structure in IDDM women with low glomerular filtration rate and normal urinary albumin excretion. Diabetes. 1992;41:581–586.
26. Tervaert T.W., Mooyaart A.L., Amann K. et al. Pathologic classification of diabetic nephropathy. J Am Soc Nephrol. 2010;21(4):556–563.


Об авторах / Для корреспонденции


Волкова Н.И. – заведующая кафедрой внутренних болезней № 3 ГОУ ВПО РостГМУ Минздравсоцразвития России, директор Ростовского-на-Дону городского эндокринологического центра.
E-mail: n_i_volkova@mail.ru;
Антоненко М.И. – ассистент кафедры внутренних болезней № 3 ГОУ ВПО РостГМУ Минздравсоцразвития России


Похожие статьи


Бионика Медиа